The fight for affordable insulin
Today, Explained
Insulin Price Caps and Market Dynamics
This chapter explores the introduction of a $35 monthly cap on insulin prices by Eli Lilly and its implications for both insured and uninsured patients. It delves into the ongoing protests for more affordable insulin, personal struggles tied to high costs, and legislative actions aimed at addressing the market failures in insulin pricing.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
